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Normal development of the cardiac atrioventricular (AV) endocardial cushions is essential for proper ventricular septation and
morphogenesis of the mature mitral and tricuspid valves. In this study, we demonstrate spatially restricted expression of both Wnt-9a
(formerly Wnt-14) and the secreted Wnt antagonist Frzb in AV endocardial cushions of the developing chicken heart. Wnt-9a expression is
detected only in AV canal endocardial cells, while Frzb expression is detected in both endocardial and transformed mesenchymal cells of the
developing AV cardiac cushions. We present evidence that Wnt-9a promotes cell proliferation in the AV canal and overexpression of Wnt-9a
in ovo results in enlarged endocardial cushions and AV inlet obstruction. Wnt-9a stimulates h-catenin-responsive transcription in AV canal
cells, duplicates the embryonic axis upon ventral injections in Xenopus embryos and appears to regulate cell proliferation by activating a
Wnt/h-catenin signaling pathway. Additional functional studies reveal that Frzb inhibits Wnt-9a-mediated cell proliferation in cardiac
cushions. Together, these data argue that Wnt-9a and Frzb regulate mesenchymal cell proliferation leading to proper AV canal cushion
outgrowth and remodeling in the developing avian heart.
D 2004 Published by Elsevier Inc.
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The primitive heart consists of an outer myocardial cell
layer and an inner endocardial cell layer separated by an
acellular extracellular matrix (ECM) termed cardiac jelly
(Kitten et al., 1987). Following initiation of cardiac looping
localized increased extracellular matrix (ECM) secretion
from the myocardium at the junctions between the atrium
and ventricle (atrioventricular canal) and along the outflow
tract creates thickened luminal projections called endocar-
dial cushions (Markwald et al., 1975, 1977). During cardiac
cushion epithelial–mesenchymal cell transition (EMT), a0012-1606/$ - see front matter D 2004 Published by Elsevier Inc.
doi:10.1016/j.ydbio.2004.10.013
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E-mail address: aperson@email.arizona.edu (A.D. Person).subpopulation of endocardial cells within the AV and
outflow tract cushions proliferate and transform into
migratory mesenchymal cells that populate the cardiac jelly
between the endocardium and myocardium (Markwald et
al., 1975, 1977). Lineage tracing experiments demonstrate
that AV canal cushion mesenchymal cells contribute to the
mature mitral and tricuspid valve leaflets as well as the
interatrial and interventricular septa (de la Cruz et al., 1977,
1983; Lamers et al., 1995).
The majority of studies investigating cardiac cushion
morphogenesis have focused on the process of epithelial–
mesenchymal cell transition (EMT) (Akiyama et al., 2004;
Brown et al., 1996, 1999; Camenisch et al., 2000; Galvin et
al., 2000; Kim et al., 2001; Kitamura et al., 1999; Krug et
al., 1985, 1987; Nakajima et al., 1997a,b; Potts and Runyan,
1989; Potts et al., 1991; Runyan and Markwald, 1983).278 (2005) 35–48
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cushions is one of many developmental events necessary for
proper heart valve morphogenesis. While restricted cardiac
cushion expression of BMP-4 and NFATc is observed
during EMT, genetic null models suggest direct roles for
these candidate genes in cell proliferation, rather than EMT,
during cushion morphogenesis (de la Pompa et al., 1998;
Jiao et al., 2003; Ranger et al., 1998). In addition, although
FGF-4 is expressed in developing chicken endocardial
cushions during EMT, FGF-4 appears to affect cell
proliferation important for later cushion remodeling and
does not play a role in cushion EMT (Sugi et al., 2003).
Within the embryonic cardiac cushions, endocardial cells
and newly formed mesenchymal cells display increased
BRDU incorporation (De la Cruz and Markwald, 1998) and
a gradient of proliferating cell nuclear antigen (PCNA)
staining near the leading edge of the cushion projections
(Abdelwahid et al., 2002). This gradient of cell proliferation
has been proposed to promote directional outgrowth of
cushions ultimately leading to mature valve leaflet for-
mation (De la Cruz and Markwald, 1998). Apoptosis also
seems to be involved in cardiac cushion remodeling.
Apoptotic cells are found at low levels throughout the
cushions with increased programmed cell death observed in
cushion mesenchyme adjacent to the myocardium (Abdel-
wahid et al., 2002). Focal apoptosis within cardiac cushions
may play a role in shaping early cushions into elongated
mature valve leaflets. Thus, the coordinated balance of cell
proliferation and apoptosis appears necessary for normal
endocardial cushion outgrowth and remodeling.
Canonical Wnt glycoproteins (Wnt-1, Wnt-3a, Wnt-8)
bind to Frizzled transmembrane receptors initiating a
signaling cascade resulting in h-catenin nuclear trans-
location and activation of h-catenin responsive genes
(reviewed by Miller, 2002). Many examples exist of Wnt/
h-catenin signaling modulating cell proliferation throughout
development and cancer (reviewed by Smalley and Dale,
1999). h-catenin activity affects cell proliferation with
molecular studies revealing activating mutations of canon-
ical Wnt signaling pathway components in 90% of color-
ectal cancers (reviewed in Giles et al., 2003). Wnt/h-catenin
signaling also influences cell proliferation during embryo-
genesis. Wnt-1 and Wnt-3a stimulate cell proliferation in the
developing neural tube and somites (Galli et al., 2004;
Megason and McMahon, 2002). In addition, h-catenin
activity regulates cell survival and proliferation in the
developing mammary gland with activated h-catenin
resulting in mammary gland neoplasia (Gallagher et al.,
2002; Imbert et al., 2001; Rowlands et al., 2003). Wnt/h-
catenin regulation of the transcription factor Pitx2 leads to a
cascade of cell proliferation signals necessary for neural
crest cell migration (Kioussi et al., 2002).
Recent reports using transgenic zebrafish and mouse
embryos expressing h-catenin responsive reporter genes
reveal an important role for h-catenin signaling in endo-
cardial cushion morphogenesis (Gitler et al., 2003; Hurl-stone et al., 2003). The hearts of zebrafish embryos with
mutations in APC or Axin, both negative regulators of h-
catenin signaling, exhibit ectopic h-catenin activity,
expanded cardiac cushions, and increased cell proliferation
(Hurlstone et al., 2003). Although downstream components
of Wnt/h-catenin signaling are clearly involved in cardiac
cushion development, the specific Wnt directing h-catenin-
mediated cell proliferation in the cardiac cushions is not
currently known. Here we show that Wnt-9a signals through
h-catenin in the developing avian AV canal cushions. Wnt-
9a overexpression increases AV cushion mesenchymal cell
proliferation while a Wnt-9a truncation mutant, Wnt-9aD288,
increases mesenchymal cell apoptosis. We also present
evidence that Frzb inhibits Wnt-9a-induced cell prolifer-
ation in avian AV canal cardiac cushions.Materials and methods
Whole-mount and section in situ hybridizations
Specific cDNAs for chicken Wnt-9a (bp 231–800;
GenBank no. AF031168) and chicken Frzb (bp 423–918;
GenBank no. AF218057) were isolated by RT-PCR from
HH stage 16 AV canals and cloned into pSTBlue-1
(Novagen). Whole-mount in situ hybridization protocols
and Digoxigenin (DIG)-labeled riboprobe synthesis for
chicken Wnt-9a and Frzb probes were as described (Nieto
et al., 1996). Images of whole-mount embryos were
captured on a dissecting microscope (Lieca model
MZ125) with a digital camera (Nikon Cool Pix 995).
For in situ hybridization on sections, dissected embryos
were fixed overnight in a 6:3:1 solution of ethanol/formalin/
acetic acid prior to paraffin embedding and sectioning.
Slides were briefly treated with proteinase K (20 ug/ml) for
7 min and post-fixed in 4% paraformaldehyde prior to
overnight incubation in hybridization buffer containing
DIG-labeled riboprobe (250 ng/ml) at 658C. Slides were
washed in SSC/50% formamide/0.1% Tween20 before
overnight incubation at 48C with an anti-DIG antibody
(Roche) diluted 1/2000 in MABT (100 mM maleic acid pH
7.5, 150 mM NaCl, 1%Tween 20) with 20% goat serum and
2% blocking reagent (Roche). Slides were washed in
MABT prior to color detection with NBT (Roche) and
BCIP (Roche) in NTMT buffer (100 mM Tris pH 9.5, 100
mM NaCl, 50 mM MgCl2 and 1% Tween 20). Images were
captured on an inverted microscope (Leica) equipped with
Normarski Optics.
RCAS production and characterization
A RCASBPA proviral construct expressing full-length
Wnt-9a was generously provided by Dr. Cliff Tabin
(Hartmann and Tabin, 2001). Based upon published reports
of truncated Wnts that function in a dominant-negative
manner (Hoppler et al., 1996), a C-terminal truncated Wnt-
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Expand High Fidelity DNA Polymerase (Roche) using
RCASBPA Wnt-9a proviral plasmid as a template with
primers (5VCCATCGATTCTAGACCACTGTGG 3V and
5VCCATCGATTCACAAAAGCTTGGGGAA 3V). Cla1
sites engineered into the PCR primers were used to ligate
the Wnt-9a C-terminal truncation mutant (Wnt-9aD288) into
a RCASBPA proviral plasmid. Proviral constructs were
transfected with Lipofectamine (Invitrogen) into avian DF-1
fibroblasts and concentrated virus (5  108 to 8  108 IU/
ml) was collected as described (Morgan and Fekete, 1996).
Western blot analysis of infected DF-1 cell lysates was
performed using an affinity-purified polyclonal Wnt-9a anti-
peptide antibody produced in rabbits injected with the
following peptide (VCDRLKLEKKQRRMCR).
In vitro RCAS studies
Concentrated RCAS viruses (100 nl) containing full-
length Wnt-9a, Wnt-9aD288, or no insert control were
injected directly into the heart lumen of Hamburger and
Hamilton (HH) (Hamburger and Hamilton, 1951) stage 11
avian embryos explanted onto egg agar plates (Darnell and
Schoenwolf, 2000) using a micromanipulator (Leica). Prior
to injection, 1 Al of 0.1% fast green dye was added to 20 Al
of each virus for visualization. Embryos were incubated at
378C to stage 15 prior to AV canal isolation and cultured on
hydrated collagen I gels as described (Romano and Runyan,
1999). After 24 h of culture, the number of AV canal
mesenchymal cells observed within the collagen gel were
manually counted by two independent observers. For each
experiment, a minimum of 16 AV canal explants were
examined.
Real-time PCR
Total RNA (250 ng) isolated from AV canal explants
infected with either RCAS Wnt-9a, RCAS Wnt-9aD288, or
RCAS control was used in real time RT-PCR reactions with
primers for Wnt-9a (F = 5V-CTCAAAGTGGGCAGCAC-
TAC-3V; R = 5V-TGGGGAATCGTCAATGTAGA-3V) using
the Quantitect SYBR RT-PCR Kit (Qiagen). These Wnt-9a
PCR primers hybridize to both endogenous and exogenous
Wnt-9a cDNAs. Real-time reactions were each done in
triplicate on a Rotogene 3000 Real-Time PCR machine.
Wnt-9a amplification was normalized to h-actin amplifica-
tion for each experimental treatment.
b-catenin TOPFLASH reporter assays
Stage 15 AV canals where isolated from RCAS infected
embryos and explanted onto collagen I gels as described
above. For these studies, 40 AV canal explants were
cultured on a single collagen I gel. TOPFLASH or
FOPFLASH (6 Ag) (Upstate Biotech) and 0.3 Ag of
pCMV-RL (Promega) were transfected into AV canal tissueswith 5 Al of Lipofectamine (Invitrogen) in 150 Al of Media
199 (Invitrogen) for 2 h at 378C. AV canal cultures where
incubated for an additional 24 h in Media 199 with 1%
chick serum and Pen/Strep antibiotics (Invitrogen). Firefly
luciferase and Renilla luciferase activities were determined
with a Luminomitor (TD-20/20, Turner Designs) using the
Dual Luciferase System (Promega).
Xenopus injections
Full-length Wnt-9a and Wnt-9aD288 were directionally
cloned into the T7TS RNA expression vector (Cleaver et al.,
1996). Capped mRNAs were synthesized in vitro from
BamHI linearized pT7TS-Wnt-9a and pT7TS-Wnt-9aD288
using the T7 Message Machine in vitro transcription kit
(Ambion). XWnt-8 in pSP64T (Christian et al., 1991) and
XWnt-5a in pSP64T (Moon et al., 1993) were linearized
with BamHI and Xba1, respectively, and capped mRNAwas
synthesized using the SP6 Message Machine in vitro
transcription kit (Ambion). Wnt-9a, Wnt-9aD288, XWnt-8,
or XWnt-5a mRNA were injected into a ventral vegetal
blastomere at the four-cell stage. Wnt-9a- and XWnt-8-
injected Xenopus embryos were examined at stage 27 for
duplicated axes. XWnt-5a-injected embryos were scored at
stage 15 for gastrulation defects. In situ hybridizations were
performed as described (Harland, 1991) on stage 11
embryos using an XNot-1 DIG-labeled riboprobe to mark
the dorsal mesoderm.
AV canal cell proliferation and apoptosis in vitro
Stage 15 AV canals infected with RCAS were isolated
and explanted onto collagen I gels as described above. After
incubation for 48 h, 100 AM of BRDU (BD Biosciences)
was added for 5 h before fixation in 4% paraformaldehyde.
BRDU incorporation was detected with an anti-BRDU
antibody (BD Biosciences) diluted 1:200 and a donkey anti-
mouse Texas Red conjugated secondary antibody (Jackson
Laboratories) diluted 1:500. For apoptosis determinations,
TdT-mediated dUTP Nick-End Labeling (TUNEL) staining
was performed using the DeadEnd Fluorometric TUNEL
System (Promega) on infected AV canal explants. Nuclei
were counterstained with DAPI (10 Ag/ml). Collagen gels
were mounted on slides and 0.2-Am optical sections were
captured using a deconvolution microscope (Deltavision).
The percentage of BRDU-positive cells/DAPI-positive cells
and TUNEL-positive cells/DAPI-positive cells were
counted in 20 explants for each treatment.
Frzb studies
Recombinant Frizzled Related Protein-3 (FRP-3) (R&D
Systems), the mouse orthologue of chicken Frzb, was used to
treat stage 15 avian AV canals cultured in vitro. AV canals
were isolated from either naRve embryos or embryos infected
with RCAS Wnt-9a at stage 11 as described above. Mouse
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ng/ml in Media 199 with 1% chicken serum and Pen/Strep
antibiotic. After 24 h in culture, mesenchymal cells beneath
the gel surface were counted as described above.
To specifically target Frzb, antisense oligodeoxynucleo-
tide experiments were performed as described (Romano and
Runyan, 1999). Unmodified 16-mer oligodeoxynucleotides
(Integrated DNA Technologies) were designed from the
chicken Frzb sequence (GenBank no. AF218057) as follows:
asFrzb (731–746) ACAGAGGCAGCCGGAG; asFrzb
(801–816) AGAGTAACCTGGAGCG; and a reverse com-
pliment control asFrzb (731–746 control) TGTCTCC-
GTCGGCCTC. Antisense treatments of explanted AV
canals were performed as described (Romano and Runyan,
1999; Runyan et al., 1999). After 24 h in culture, mesen-
chymal cells were counted by two independent observers.
In vivo studies
To assess the effects of Wnt overexpression on AV canal
morphogenesis in vivo, 100 nl of RCAS virus was injected
into the heart lumen of stage 15 embryos explanted on egg
agar. The embryos were then incubated at 378C for 42 h
prior to fixation, embedding, and sectioning. Cell prolifer-
ation and viral infection were determined using a mono-
clonal anti-PCNA (Zymed) 1:200 and a polyclonal anti-
retroviral GAG antibody (p27) (Spafas) 1:200, respectively.
TUNEL staining was also performed as described above.
Goat anti-rabbit (Cy5) (Sigma) and donkey anti-mouse (TR)
(Jackson Laboratories) secondary antibodies were used for
double-channel immunofluorescence imaging. The percent-
age of TUNEL-positive mesenchymal cells and viral
infected mesenchymal cells showing PCNA staining withinFig. 1. Expression of Wnt-9a in the AV canal cushion endocardium. Whole-mou
cardiac cushions of chicken hearts at stage 16 (A), stage 20 (B), and stage 24 (C).
show Wnt-9a expression localized to the endocardial cell layer (arrows) of the A
myocardium; E = endocardium.the AVendocardial cushions was determined in serial optical
sections for Wnt-9a, Wnt-9aD288, and control infected
embryos on a deconvolution microscope (Deltavision).
To define the long-term consequences of Wnt-9a over-
expression on valve development, RCASBPA constructs
were injected in ovo into the sinus venosus of windowed
eggs at HH stage 11. This approach was required because
avian embryos explanted onto egg agar do not develop
beyond stage 20 (Darnell and Schoenwolf, 2000). After
injections, the eggs were sealed with parafilm and incubated
at 378C until stage 26 or stage 33. Hearts were isolated and
gross heart morphology was imaged. Dissected hearts were
fixed in 4% paraformaldehyde, embedded and sectioned.
Sections were immunostained with a monoclonal anti-GAG
antibody (AMV-3C2, Developmental Studies Hybridoma
Bank, University of Iowa) diluted 1:5 in PBS blocking
buffer (0.1% Triton X-100/10% horse serum). Secondary
detection was performed with the Peroxidase MIgG
Vectastain Elite ABC kit (Vector Laboratories) and visual-
ized with DAB staining (Vector Laboratories).Results
Wnt-9a expression is restricted to AV canal endocardial
cells during early valve development
Wnt-9a expression is initially detected at Hamburger and
Hamilton (HH) (Hamburger and Hamilton, 1951) stage 16
in the endocardial cell population of the AV canal cushions
(Figs. 1A, D). At stage 20, intense staining for Wnt-9a
transcripts is observed in the AV canal endocardium (Figs.
1B, E). Restricted endocardial AV canal expression of Wnt-nt in situ hybridizations demonstrating Wnt-9a expression in the AV canal
Section in situ hybridizations of stage 16 (D), stage 20 (E), and stage 24 (F)
V canal cardiac cushions. Abbreviations: A = atrium; V = ventricle; M =
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cushions are extensively populated with mesenchymal cells
at stage 24 (Figs. 1C, F). In all stages examined, Wnt-9a
expression is not detected in transformed mesenchymal
cells of AV canal cardiac cushions or in cardiac myocytes
(Figs. 1D–F).
Wnt-9a stimulates cell proliferation in AV cardiac cushions
in vitro
To investigate the role of Wnt-9a in AV canal cushion
morphogenesis, we used an avian replication competent
retrovirus (RCAS) to overexpress Wnt-9a in the heart. Wnt-
9aD288 was generated by truncating the C-terminus of theFig. 2. Production and characterization of RCAS Wnt-9a and Wnt-9aD288. (A) Ali
C-terminal truncations of both mWnt-1 and XWnt-8 after the SPXXC motif (box
1996). A similar 288 amino acid avian Wnt-9a construct (Wnt-9aD288) was generat
Western blot analysis of DF-1 cell lysates infected with RCAS Wnt-9a and Wnt-9a
detected in DF-1 cells infected with RCAS control virus.coding sequence, after the SPSFC motif, similar to reported
dominant-negative mWnt-1 and XWnt-8 constructs (Hop-
pler et al., 1996) (Fig. 2A). Western blot analysis of avian
DF-1 fibroblasts infected with RCAS containing either the
Wnt-9a or Wnt-9aD288 proviral constructs confirm expres-
sion of a proteins consistent with the predicted sizes of ~45
and ~38 kDa, respectively (Fig. 2B).
To directly test the role of Wnt-9a in AV canal
development, RCAS Wnt-9a and RCAS Wnt-9aD288 were
used to infect AV canals. As studies using RCAS
demonstrate viral protein detection 18 h after infection
(Morgan and Fekete, 1996), virus was injected into the
lumen of stage 11 hearts 24 h prior to AV canal EMT. In
situ hybridization detected extensive infection of RCASgnment of mWnt-1 and XWnt-8 with chicken Wnt-9a nucleotide sequences.
) create Wnts that function as dominant-negative inhibitors (Hoppler et al.,
ed by truncating the C-terminal 66 amino acids after the SPSFC domain. (B)
D288 viruses detect proteins of ~45 and ~38 kDa, respectively. Wnt-9a is not
Fig. 3. Wnt-9a and Wnt-9aD288 affect cell proliferation and apoptosis in AV
canal cultures. (A) Infections of AV canal cultures with RCAS Wnt-9a
results in a significant increase in migratory mesenchymal cells compared
to RCAS control infected AV canal cultures. Infection of AV canal cultures
with RCAS Wnt-9aD288 results in a decrease in migratory mesenchymal
cells compared to RCAS control infected AV canal cultures. (B) Real-time
PCR data showing infections of AV canal cultures with RCAS Wnt-9a and
RCAS Wnt-9aD288 resulting in a 6.3- and 7.7-fold expression increase
respectively over endogenous Wnt-9a in RCAS controls. (C) AV canal
cultures infected with RCAS Wnt-9a show an increase in BRDU
incorporation compared to RCAS control infected AV canal cultures.
RCAS Wnt-9aD288-infected cultures did not show differences in BRDU
incorporation compared to controls. (D) Wnt-9a overexpression in AV canal
explants resulted in decreased TUNEL staining compared to RCAS
controls. Overexpression of Wnt-9aD288 results in an increase in TUNEL
staining compared to controls (D). All experiments consisted of at least 16
AV canal explants and were performed in triplicate.
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stage 15, the AV canals of infected embryos were
explanted onto collagen I gels to assay for mesenchymal
cell formation as described (Romano and Runyan, 1999).
AV canal explants from RCAS Wnt-9a-injected hearts
displayed N100% increase in mesenchymal cell number
compared to controls (Fig. 3A). Infection of AV canals
with RCAS Wnt-9aD288 attenuated mesenchymal cell
formation resulting in a 73% reduction in migratory
mesenchymal cells compared to controls (Fig. 3A). This
approach for RCAS delivery of Wnt constructs resulted in
N6-fold transgene expression above endogenous AV canal
Wnt-9a detected in RCAS control infected AV canals as
assayed by real-time PCR (Fig. 3B).
Several studies report that Wnts promote cell proliferation
during development (Kioussi et al., 2002; Reya et al., 2000;
Shu et al., 2002). AV canals infected with RCAS Wnt-9a
displayed a significant increase in BRDU incorporation
compared to control AV canals (Fig. 3C). In contrast, Wnt-
9aD288 did not alter BRDU incorporation (Fig. 3C). Thus,
increased cushion mesenchymal cells observed in Wnt-9a
overexpression studies are due, at least in part, to increased
cell proliferation. Studies in tumor cells have shown that
Wnts can promote cell survival (Chen et al., 2001; Longo et
al., 2002; You et al., 2002) and inhibiting Wnt signaling
leads to programmed cell death (He et al., 2004). In AV canal
cultures, Wnt-9aD288 overexpression results in a significant
increase in TUNEL-positive cells compared to control or
Wnt-9a-infected AV canals (Fig. 3D). Wnt-9a-infected AV
canals show a reduction in TUNEL-positive cells compared
to controls (Fig. 3D).
Wnt-9a activates b-catenin signaling
The TOPFLASH/FOPFLASH h-catenin reporter system
was used to address whether the Wnt-9a-mediated increase
in cell proliferation during AV canal cushion morpho-
genesis is due to h-catenin activation. This TOPFLASH/
FOPFLASH reporter system has been used extensively to
assay for h-catenin activity in a variety of systems (Liu et
al., 2003; Nakamura et al., 2003; van de Wetering et al.,
1997). The TOPFLASH reporter contains three copies of
the optimal T-Cell Factor (TCF) transcription factor binding
motif upstream of a minimal c-Fos promoter driving
luciferase expression. The FOPFLASH reporter has
mutated TCF binding sites and does not respond to h-
catenin activity (van de Wetering et al., 1997). AV canal
explants infected with RCAS Wnt-9a show a 4.6-fold
activation of the TOPFLASH reporter compared to the
negative control FOPFLASH reporter with mutated TCF
binding sites (Fig. 4A).
Injection of Wnt mRNA into a ventral vegetal blastomere
of Xenopus embryos at the 4-cell stage is an established
method to classify Wnts as canonical or noncanonical. In this
assay, early ventral injections of Wnts that increase h-catenin
stability cause axis duplications (Sokol et al., 1991). Wnt-9a
Fig. 4. Wnt-9a activates h-catenin in AV canals and causes axis duplications in Xenopus embryos. (A) AV canal explants infected with RCAS Wnt-9a activate
the h-catenin responsive TOPFLASH reporter but not the FOPFLASH reporter containing mutated TCF binding sites. Infection of AV canal explants with
RCAS control virus does not activate the TOPFLASH or FOPFLASH reporter. (B) Wnt-9a mRNA (50 pg) injected into a ventral blastomere of four-cell
Xenopus embryos causes duplication of the embryonic axis. Co-injecting 50 pg of Wnt-9a with 200 pg (C) or 500 pg (D) of Wnt-9aD288 rescues axis
duplications. Injection of 50 pg of XWnt-8 also results in axis duplications (E) that are not rescued with co-injection with 200 pg of Wnt-9aD288 (F). Co-
injection of Xwnt-8 with 500 pg of Wnt-9aD288 partially rescues XWnt-8-induced twinning as two cement glands are still evident (G). Uninjected embryos
showing Xnot-1 expression in the mesoderm overlying the dorsal blastopore lip (H). Stage 11 embryos injected with 50 pg of Wnt-9a mRNA show ectopic
Xnot-1 expression consistent with secondary axis formation (I). This ectopic Xnot-1 expression is no longer detected in embryos co-injected with Wnt-9a (50
pg) and Wnt-9aD288 (500 pg) (J). Uninjected control embryos at stage 15 undergoing normal gastrulation (K). Ventral injection of XWnt-5a inhibits convergent
extension creating gastrulation defects (L). These gastrulation defects caused by XWnt-5a injections are not rescued by co-injection with 500 pg of Wnt-9aD288
(M). Abbreviation: C = cement gland.
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significant number of embryos (Fig. 4B and Table 1). Co-
injection of 200 pg of Wnt-9aD288 with 50 pg of Wnt-9a
reduces duplicated axes to near background levels (Fig. 4C
and Table 1). This low level of axis duplication is not further
reduced by co-injecting 500 pg of Wnt-9aD288 (Fig. 4D and
Table 1).The dorsal mesoderm marker Xnot-1 is normally
expressed in uninjected embryos adjacent to the blasto-
pore lip of gastrulating stage 11 embryos (Fig. 4H). Xnot-
1 is expressed ectopically in Wnt-9a-injected embryos
consistent with double-axis formation (Fig. 4I). In
contrast, localized Xnot-1 expression is only detected
directly above the blastopore lip in Wnt-9a/Wnt-9aD288
Table 1
Percentage of Xenopus embryos with duplicated axes or defective
gastrulation produced by ventral injection of various Wnts in the presence




(200 pg) (500 pg)


























a Embryos scored for duplicated axes at stage 27.
b Canonical Wnt previously demonstrated to cause axis duplications
(Christian et al., 1991).
c 200 pg of Wnt-9aD288 injected alone.
d 500 pg of Wnt-9aD288 injected alone.
e Embryos scored for defective gastrulation at stage 15.
f Noncanonical Wnt previously demonstrated to inhibit convergent
extension (Moon et al., 1993).
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Wnt-9a activates a h-catenin signaling pathway and that
Wnt-9aD288 functions as a dominant-negative inhibitor of
Wnt-9a.
The specificity of Wnt-9aD288 for Wnt-9a was further
examined by co-injection with XWnt-8 or XWnt-5a.
XWnt-8 efficiently produces duplicated axes when
injected ventrally in Xenopus embryos (Christian et al.,
1991). Injections of 50 pg of XWnt-8 mRNA results in a
majority of embryos with duplicated axes (Fig. 4E and
Table 1). Co-injection of 50 pg of XWnt-8 with 200 pg
of Wnt-9aD288 mildly reduces the number of axis
duplications, and co-injection with 500 pg of Wnt-
9aD288 reduces axis duplications in half (Figs. 4F, G
and Table 1). Therefore, Wnt-9aD288 can inhibit XWnt-8
function but not as efficiently as it inhibits Wnt-9a
function. Ventral injection of XWnt-5a does not result in
axis duplication (Moon et al., 1993), but inhibits
convergent extension resulting in gastrulation defects
(Du et al., 1995; Moon et al., 1993). XWnt-5a (50 pg)
injected into a ventral blastomere of 4-cell Xenopus
embryos results in severe gastrulation defects in 70% of
embryos (Fig. 4L and Table 1). Co-injection of either 200
or 500 pg of Wnt-9aD288 with 50 pg of XWnt-5a does
not inhibit XWnt-5a-induced gastulation defects (Fig. 4M
and Table 1). We conclude that Wnt-9aD288 inhibits Wnt-
9a and to a lesser extent XWnt-8, but does not inhibit
non-canonical XWnt-5a signaling.
Frzb expression in the AV canal endocardial cushions
Expression of secreted Wnt antagonist, Frzb, was
reported in the AV canal endocardium and transformedmesenchymal cells of stage 24 AV endocardial cushions
(Ladher et al., 2000). To determine if Frzb is expressed
during earlier stages of avian endocardial cushion
morphogenesis, in situ hybridizations were performed
from stages 16 through stage 24 (Fig. 5). Expression of
Frzb at stage 16 is primarily seen in the AV canal
endocardial cell population (Figs. 5A, D). Newly formed
mesenchymal cells also show expression at stage 16 (Fig.
5D). By stage 20 (Figs. 5B, E) and stage 24 (Figs. 5C,
F), expression of Frzb remains restricted to the endo-
cardial cushions. However, in contrast to continued Wnt-
9a expression limited to AV canal endocardial cells (Fig.
1), Frzb is expressed by endocardial and mesenchymal
cells of the AV canal during early cushion development
(Fig. 5).
Frzb inhibits Wnt-9a-induced AV cushion mesenchyme
proliferation
The addition of recombinant Frizzled Related Protein-3
(FRP-3), the mouse orthologue of chicken Frzb, to AV
canal explant cultures results in a reduction in mesenchy-
mal cells (Fig. 6A). FRP-3 at 10 or 30 ng/ml results in a
similar ~60% reduction in mesenchymal cell number
arguing that doses of 10 ng/ml saturate Wnt activity in
this culture system (Fig. 6A). To further investigate Frzb
function, Frzb antisense oligodeoxynucleotides were used
to perturb Frzb in AV canal explants. This approach has
proven effective in the study of other factors in the AV
canal explant system (Potts et al., 1991; Romano and
Runyan, 1999). Consistent with Frzb functioning as a
negative regulator of Wnt signaling, targeted degradation
of Frzb mRNA with two independent antisense oligos
resulted in amplified mesenchymal cell numbers in AV
canal explants (Fig. 6B).
To test if Frzb inhibits Wnt-9a signaling during AV canal
development, Wnt-9a-infected AV canals were treated with
exogenous FRP-3. FRP-3 offset the Wnt-9a-mediated
increase in cell proliferation in a dose-dependent manner
(Fig. 6C). These data suggest that Frzb acts to modulate
Wnt-9a-induced mesenchyme cell proliferation in the
developing AV canal.
Overexpression of Wnt-9a and Wnt-9aD288 in vivo
Cell proliferation and apoptosis were examined in the
developing AV endocardial cushions of avian embryos at
stage 18 following injection with RCAS containing either
full-length Wnt-9a or dominant-negative Wnt-9aD288 con-
structs. At stage 18, Wnt-9a overexpressing endocardial
cushions are larger in size with more mesenchymal cells
compared to controls (Fig. 7B). Wnt-9a-infected cushions
contained 112 F 11 cells compared to 46 F 5 mesen-
chymal cells in control hearts. Stage 18 AV endocardial
cushions infected with Wnt-9aD288 displayed 35 F 5 cells.
The percentage of viral-infected mesenchymal cells under-
Fig. 5. Frzb is expressed in the endocardial and mesenchymal cells of the AV canal cushions. Whole-mount in situ hybridizations show Frzb expression in the
AV canal cushions at HH stage 16 (A), stage 20 (B), and stage 24 (C). In situ hybridization analysis of sections reveals Frzb is expressed in the endocardium
and transformed mesenchyme of AV canal cushions at stage 16 (D), stage 20 (E), and stage 24 (F). Frzb expression is absent from the myocardium at all stages
examined. Abbreviations: A = atrium; V = ventricle; E = endocardium; M = myocardium.
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PCNA co-immunolocalization, was 29.1% in RCAS Wnt-
9a-infected hearts (n = 5), 16.9% in RCAS Wnt-9aD288-
infected hearts (n = 5), and 14.4% in controls (n = 5).
PCNA immunostaining also appeared more pronounced in
the endocardial cell layer of hearts infected with RCAS
Wnt-9a (Fig. 7B). Consistent with AV canal explant
results, in vivo TUNEL staining of infected cushions
reveals increased TUNEL-positive cells in dominant-
negative Wnt-9aD288-infected cushions (9.8%) compared
to controls (5.4%). Cushions from Wnt-9a overexpressing
hearts displayed only (4.4%) TUNEL-positive mesenchy-
mal cells (Figs. 7D–F).
RCAS injections were performed in ovo to determine
the effects of Wnt-9a perturbation on later stages of
cardiac valve development. Wnt-9a overexpression
caused a reproducible phenotype with expanded, hyper-
proliferative cushions that created an elongated inlet
between the atrium and ventricle at HH stage 26 (Figs.
7K, L). While control hearts display single endocardial
cushion luminal projections at stage 26, Wnt-9a-infected
cushions have multiple ectopic projections (Figs. 7H,
L). Wnt-9a-infected hearts have massive atrial enlarge-
ment and atrial blood pooling, consistent with signifi-
cant AV inlet stenosis (Fig. 7K). By stage 33, the AV
canal normally forms separate mitral and tricuspid in-
lets (Figs. 7I, J). In contrast, hearts infected with domi-
nant-negative Wnt-9aD288 exhibit arrested development
and maintain a single AV junction at stage 33 (Fig.
7M). Dominant-negative Wnt-9aD288 hearts at this stage
display hypocellular endocardial cushions, delayed car-
diac looping, and severe cushion hypoplasia (Figs.
7M, N).Discussion
Cardiac cushion morphogenesis encompasses several
steps leading to formation of mature valvular and septal
structures. After the bilateral heart primordia in the lateral
plate mesoderm coalesce to form a tubular heart, regional
increases in extracellular matrix secretion at the AV and
outflow tract regions results in the formation of cardiac
cushions. Endocardial cells within these cardiac cushions
then receive inductive signals from the myocardium leading
to the formation of migratory mesenchymal cells that
populate the cardiac jelly (Runyan and Markwald, 1983).
Subsequent morphogenic events include directional cushion
elongation and eventual formation of mature valve leaflets
as well as completion of chamber septation. The molecular
mechanisms of later cushion outgrowth and remodeling are
just beginning to be understood.
In this study, we demonstrate that Wnt-9a directs cell
proliferation in the developing avian cardiac AVendocardial
cushions. Viral-mediated overexpression of Wnt-9a in vitro
and in vivo supports this. Wnt-9a overexpression increases
cell proliferation and mesenchymal cell number in the AV
canal explant system, and results in enlarged, hyperproli-
fertative cushions in ovo (Fig. 7). Cushion formation is not
detected outside the normal cushion forming regions,
arguing that Wnt-9a overexpression is not sufficient to
induce ectopic EMT. In addition, a dominant-negative Wnt-
9a does not completely inhibit mesenchyme formation in
cardiac cushions (Fig. 7); rather, Wnt-9aD288 increases
apoptosis leading to a reduction in cushion mesenchyme
(Fig. 7). These data suggest that Wnt-9a is not a critical
stimulus for the change in endothelial to mesenchymal
phenotype in the developing avian AV canal, but rather is an
Fig. 6. Frzb is a dose-dependent negative regulator of Wnt-9a-mediated cell
proliferation. (A) Addition of recombinant FRP-3, the mouse orthologue of
chicken Frzb, results in a decrease in mesenchymal cell number in AV canal
cultures. (B) Treatments of AV canal explants with two distinct Frzb
antisense oligodeoxynucleotides result in an increase in mesenchymal cell
number compared to controls (Lipofectamine alone and control oligo
treatments). (C) Infection of AV canal cultures with RCAS Wnt-9a results
in an increase in mesenchymal cell number while treating RCAS Wnt-9a-
infected cultures with FRP-3 at 10 ng/ml reduces mesenchymal levels to
those seen in RCAS control infected cultures. FRP-3 (30 ng/ml) further
decreases mesenchymal cell number in RCASWnt-9a-infected cultures (C).
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endothelial and mesenchymal cell populations that are
critical for appropriate growth and remodeling of the AV
valves.
Previous studies have not clearly resolved the mechanism
of Wnt-9a signal transduction. Wnt-9a (formerly Wnt-14)
functions prominently to initiate synovial joint formation,
but overexpression of activated versions of h-catenin,
RhoA, CamKII, or a dominant negative Dishevelled fail to
phenocopy Wnt-9a overexpression during limb formation.
These data caused the authors to speculate that Wnt-9a may
transduce intracellular signaling by a novel mechanism(Hartmann and Tabin, 2001). We provide direct evidence
that Wnt-9a activates h-catenin responsive transcription in
AV canal cells using a h-catenin reporter assay (Fig. 4). In
addition, Wnt-9a induces axis duplications in Xenopus
embryos further arguing that Wnt-9a signals via a Wnt/h-
catenin pathway. Taken together, our data suggest that Wnt-
9a mediates h-catenin activity in the endocardial cell layer
of the avian AV canal cushions, but we cannot exclude a
role for additional related Wnts. In a survey of Wnt isoform
expression in the AV canal, Wnt-9a is the predominant Wnt
isoform expressed during cushion formation, but Wnt-6 is
expressed in a subset of myocardial cells in the AV canal
(Person et al., in preparation).
The novel C-terminal truncation Wnt-9a mutant used in
this study proved useful to perturb Wnt-9a function during
avian endocardial cushion morphogenesis. The Wnt-9a
truncation after the SPXXC motif is similar to XWnt-8 and
mouse Wnt-1 dominant negatives used in a previously
published report (Hoppler et al., 1996). The Wnt-9a
truncation effectively inhibits Wnt-9a-induced twinning in
Xenopus embryos and Wnt-9a function during avian valve
development in an apparent dominant negative manner.
While the Wnt-9aD288 construct abolished Wnt-9a effects on
axis duplication in Xenopus embryos, results with XWnt-8
and Wnt-9aD288 co-injection suggest this truncation mutant
has some potential to affect other Wnt/h-catenin pathways.
Our results in an embryonic chicken model are consistent
with reports in zebrafish mutants lacking the intracellular h-
catenin antagonist APC. Zebrafish APC mutants display
expanded expression domains of cushion markers (Has-2,
Versican, BMP-2 and Notch-1b), consistent with enlarged
cardiac cushions (Hurlstone et al., 2003). However, cardiac
mesenchymal cells are not obvious in areas outside the
normal cushion forming regions in zebrafish APC mutants
(Hurlstone et al., 2003), suggesting that activated h-catenin
is necessary for cell proliferation but is likely not sufficient
to induce ectopic EMT. A similar increase in cell
proliferation rather than cell transformation per se is
observed in human melanoma cell lines upon reducing
APC expression levels (Worm et al., 2004).
Frzb is the founding member of a larger group of secreted
frizzled related proteins (sFRPs) that share sequence
homology with frizzled transmembrane receptors. FRPs
and Wnts are often expressed in overlapping regions and
FRPs are thought to delineate Wnt signaling boundaries
during development (Jones and Jomary, 2002). The
restricted AV canal expression of Frzb and the expansion
of transformed mesenchymal cells following Frzb antisense
oligo targeting in AV canal explants suggests Frzb is a
negative regulator of avian endocardial cushion morpho-
genesis. Although inhibition of Wnt-9a-mediated cell
proliferation in avian AV canal explants supplemented with
the Frzb orthologue FRP-3 suggests a direct interaction
between these factors, FRP-3 inhibition of other endocardial
cushion Wnts, including Wnt-6 (Schubert et al., 2002),
cannot be excluded.
Fig. 7. Wnt-9a and Wnt-9aD288 affect cell proliferation, apoptosis, and cushion morphology in vivo. (A–F) Analysis of stage 18 AV endocardial cushions
following Wnt-9a perturbations. (A–C) RCAS infection (anti-p27) is shown in red and PCNA immunostaining is shown in green. Co-expressing cells are
yellow. Wnt-9a-infected AV cushions show a pronounced increase in PCNA staining in both infected endocardial and mesenchymal cells compared to control
and Wnt-9aD288-infected hearts. Arrows indicate the endocardium while arrowheads point to the myocardium of the AV canal junction. (D–F) TUNEL staining
(seen as red) is increased in cushion mesenchymal cells of Wnt-9aD288-infected hearts compared to control and Wnt-9a-infected hearts. The endocardial cell
layer is marked by a white dotted line. (G–L) Heart valve remodeling defects following Wnt-9a overexpression. (K) Wnt-9a-infected hearts at stage 26 display
an elongated AV inlet and an enlarged atrium with blood pooling. (L) Wnt-9a-treated AV cushions are enlarged, hyperplastic, and display multiple AV cushion
projections into the lumen (arrowheads). RCAS Wnt-9aD288-infected hearts, at stage 33, display looping abnormalities and a single AV inlet with hypoplastic
AV cushions (M, N). Viral infection is detected with anti-GAG immunostaining shown in red (H, J, L, N). Abbreviations: A = atrium; V = ventricle; C = conus
arteriosus; RA = right ventricle; LA = left ventricle; RA = right atrium; LA = left atrium.
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cushion formation following injections of Dkk-1 mRNA in
zebrafish embryos (Hurlstone et al., 2003). Although
expression of Dkk-1 and Dkk-3 are reported in the AV canal
endocardial cushions of mouse hearts at E12.5 p.c. (Mo-
naghan et al., 1999), it is not clear if Dkk family members
are expressed in the AV canal during the earlier stages of
cushion morphogenesis investigated in the current study.
Similar to Frzb, Dkk-1 antagonizes canonical Wnt signaling
in several developmental contexts (Fedi et al., 1999; Glinka
et al., 1998; Semenov et al., 2001). It is possible that both
Frzb and Dkk-1 regulate Wnt-9a-mediated cell proliferation
in developing avian AV cushions. Further investigations are
needed to investigate potential interplay between Wnt-9a,
Frzb, Dkk-1, and other Wnt signaling components during
cardiac cushion development.The endocardial cushion extracellular environment is
likely critical for directing cell proliferation and later valve
leaflet remodeling. Our data are consistent with a model
whereby Wnt-9a secreted from AV endocardial cells creates
a Wnt-9a concentration gradient supporting cell prolifer-
ation in proximity to the endocardium. The expression of
Frzb by mesenchymal cells in the cardiac cushions likely
plays a role in localizing cell proliferation to the proximity
of the endocardial cell layer promoting directional luminal
cushion outgrowth. Invasive cushion mesenchymal cells are
likely exposed to decreasing Wnt-9a stimulation in the
setting of persistent Frzb modulation as they migrate into
cardiac cushions. Frzb inhibition of Wnt signaling within
the cardiac cushions may promote differentiation of
mesenchymal cells already populating the cardiac jelly
leading to mature valve leaflet formation.
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morphologic differences in heart valve formation between
chickens and mice (Camenisch et al., 2002). To explore a
potential role for Wnt-9a and Frzb in mouse AV
endocardial cushion morphogenesis, the spatial expression
patterns for these factors were examined by in situ
hybridization. Consistent with published data demonstrat-
ing no significant expression of Frzb in the developing
mouse heart (Borello et al., 1999), the embryonic mouse
cardiac cushions do not express significant Frzb or Wnt-9a
(data not shown). Thus, Wnt-9a/Frzb regulation of AV
endocardial cushion cell proliferation does not appear to be
functioning during mouse development. Other Wnts and
Wnt inhibitors (Dkks) are likely responsible for regulating
cell proliferation in expanding endocardial cushions of
mammals.
It is becoming clear that endocardial cushion morpho-
genesis is dependent on multiple molecular cascades
(Akiyama et al., 2004). Our data strongly suggest that
Wnt-9a activates h-catenin signaling within AV canal
cushions, and that Wnt-9a activity is regulated my Frzb.
Important next steps in understanding Wnt-9a and Frzb
function during endocardial cushion morphogenesis will
include identification of Frizzled receptors that partner with
Wnt-9a along with defining the influences of Wnts
expressed in other cell types within the developing heart.
In addition, defining downstream effectors of Wnt-9a within
AV canal cardiac cushions will be necessary to integrate
Wnt signaling with the rapidly expanding number of genes
regulating heart valve development (Barnett and Desgro-
sellier, 2003).
In summary, we demonstrate interrelated functional roles
for Wnt-9a and the secreted Wnt antagonist Frzb during
avian AV canal cushion morphogenesis. Wnt-9a over-
expression in ovo results in hyperplastic cushions and AV
canal obstruction, while dominant-negative Wnt-9a causes
hypoplastic AV canal cushions and arrested cardiac develop-
ment. These data suggest an important role for Wnt-9a and
Frzb in the proper remodeling of AV canal cushions into
mature septal and valvular structures.Acknowledgments
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